Regorafenib Impurity 10 | CAS 2817629-88-0 - Request Quote
Regorafenib Impurity 10
| SZ CAT No: | SZ-R039025 |
| CAS No | 2817629-88-0 |
| Mol.F. | C14H13FN2O3 |
| Mol.Wt. | 276.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Regorafenib Impurity 10 is chemically Ethyl 4-(4-amino-3-fluorophenoxy)picolinate. Regorafenib Impurity 10 is supplied with detailed characterization data compliant with regulatory guideline. Regorafenib Impurity 10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Regorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2817629-88-0
Purchase 2817629-88-0
Order 2817629-88-0
Enquire 2817629-88-0
price of 2817629-88-0
2817629-88-0 Supplier
2817629-88-0 Manufacturer
2817629-88-0 Exporter
buy high quality Regorafenib Impurity 10
Purchase Regorafenib Impurity 10
Regorafenib Impurity 10 suppliers
Regorafenib Impurity 10 manufacturers
Regorafenib Impurity 10 price
Order Regorafenib Impurity 10
Enquire Regorafenib Impurity 10
Regorafenib Impurity 10 cost
Regorafenib Impurity 10 Supplier
Regorafenib Impurity 10 Distributor
Regorafenib Impurity 10 for Method Validation
Regorafenib Reference Standard
Regorafenib Impurity 10 for ANDA Filing
Regorafenib Impurity 10 for Forced Degradation Studies
Regorafenib Impurity 10 Identification Standards
Regorafenib Impurity 10 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


